Pygeum Africanum: The African Cherry Bark in Men’s Formulas

What pygeum is

Pygeum africanum — correctly Prunus africana, and a relative of the cherry and plum — is a tall evergreen hardwood found in the montane forests of sub-Saharan Africa, from Cameroon and Kenya through to Madagascar. Mature trees can reach forty metres.

The medicinal part is the bark, harvested from the trunk of mature trees. Bark is dried, milled and extracted, typically with chloroform or a similar solvent, to concentrate the lipid fraction. The finished extract is a dark, resinous material standardised for its sterol content.

Because the bark comes from living, slow-growing trees rather than an annual crop, pygeum sits in a different supply category from most botanicals. That has consequences, covered below.

Traditional and modern use

In its native range, bark preparations of Prunus africana have a long history in traditional medicine, used for a range of complaints including urinary difficulty in older men. European interest began in the mid-twentieth century, and by the 1960s a standardised extract was being produced in France and Italy for men’s preparations.

In several European countries, pygeum extract has been available for decades as a registered phytomedicine rather than as a general supplement — a different regulatory status than it has in Canada or the United States, where it is sold as a natural health product or dietary supplement.

In North American products, pygeum most often appears as a supporting ingredient in a multi-botanical men’s formula rather than on its own. ProstaDefend follows that pattern, listing it alongside saw palmetto and stinging nettle.

Constituents researchers have focused on

Three groups of compounds account for most of the scientific attention:

• Phytosterols, principally beta-sitosterol and its glucoside, which are structurally similar to cholesterol and are the fraction most extracts are standardised to.
• Pentacyclic triterpenes, including ursolic and oleanolic acid, which have been studied in laboratory models of inflammation.
• Ferulic acid esters, long-chain fatty alcohol esters that have been examined in relation to lipid metabolism.

Commercial extracts are usually standardised to 13% total sterols, a figure that appears on better labels and is a reasonable thing to look for.

What research has investigated

The clinical literature on pygeum is older and smaller than that on saw palmetto. Most trials were conducted in Europe between the 1970s and 1990s, typically enrolling modest numbers of participants over eight to sixteen weeks, and looking at self-reported urinary symptom scores in older men.

A Cochrane systematic review of this body of work concluded that the trials were generally short, small and methodologically limited by modern standards, and that better-designed studies would be needed to draw firm conclusions. That review remains the most-cited summary of the evidence and is candid about its limitations.

Separately, laboratory research has looked at how pygeum sterols behave in cell and animal models — effects on inflammatory mediators, on growth factor signalling, and on bladder tissue. Laboratory findings describe mechanism; they do not establish a clinical result in people.

You can read the underlying literature via PubMed.

Sustainability: the part most guides leave out

Demand for pygeum bark has been high enough, for long enough, to put pressure on wild populations. Harvesting bark from a standing tree can kill it if done badly, and much historical harvesting was done badly.

Prunus africana has been listed on CITES Appendix II since 1995, meaning international trade is regulated and requires export permits certifying that harvest is not detrimental to the species. Several exporting countries have faced trade suspensions over the years while management plans were put in place.

The practical consequence for a shopper is that pygeum is comparatively expensive, and that supply chain provenance is a fair question to ask a brand. Sustainably managed harvesting — taking bark in vertical strips from opposite quarters of the trunk and allowing regrowth — does exist, and cultivated plantations are being developed, but they do not yet meet global demand.

Safety and practical notes

Reported side effects in the trial literature were uncommon and mostly gastrointestinal — nausea, stomach upset or diarrhoea. Taking the dose with food is the usual practical suggestion.

• Pygeum has not been adequately studied in combination with prescription medicines. If you take anything regularly, ask a pharmacist before adding it.
• As with any supplement in this category, mention it to your doctor before a PSA test.
• It is not intended for women, children, or anyone who is pregnant or breastfeeding.
• Persistent or worsening urinary symptoms need a medical assessment. They have several possible causes, and only some of them are age-related.

Doses in the clinical literature clustered around 100–200 mg of standardised extract daily. Multi-ingredient formulas generally provide less.